Exclusive: Study in Brazil indicates Sinovac vaccine works against P1 variant found in Brazil - source


FILE PHOTO: A security guard walks outside the facility of Chinese vaccine maker Sinovac Biotech, developing an experimental coronavirus disease (COVID-19) vaccine, during a government-organized media tour in Beijing, China, September 24, 2020. REUTERS/Thomas Peter

SAO PAULO (Reuters) - Preliminary data from a study in Brazil indicates that the COVID-19 vaccine developed by China's Sinovac Biotech Ltd is effective against the P1 variant of the virus first discovered in Brazil, a source familiar with the study told Reuters on Monday.

The source, who did not provide data details, said the study had tested the blood of vaccinated people against the Brazilian variant of the virus. Coronavac, as the Sinovac shot is known, is the main vaccine currently being used to inoculate people in Brazil.

(Reporting by Eduardo Simoes; Writing by Stephen Eisenhammer; Editing by Bill Berkrot)

Article type: metered
User Type: anonymous web
User Status:
Campaign ID: 46
Cxense type: free
User access status: 3
   

Next In World

Russia jails aviation lecturer for 20 years for treason
Why India is facing an oxygen crisis as COVID cases mount
Saudi Arabia bans Lebanese produce over drug smuggling
Miner takes on Albania's political heavyweights at ballot box
India a 'devastating reminder' of damage COVID can wreak, says WHO chief
Female police officer stabbed near Paris, attacker shot - Europe 1 radio
Air Chernobyl? Tourists get chance to fly over nuclear disaster zone
In tribute to friend Deby, Macron says France will not tolerate threats to Chad
Jailed Kremlin critic Navalny starts ending his hunger strike
Rome homeless get free COVID-19 shots - and a visit from the Pope

Stories You'll Enjoy


Vouchers